The Latest in Spondyloarthropathies

Rheumatology News

Two biologics equally effective for extraintestinal manifestations of IBD

October 27, 2022

Rheumatology News

FDA approves upadacitinib (Rinvoq) for sixth indication

October 24, 2022

Rheumatology News

Who are the patients with longstanding ankylosing spondylitis without syndesmophytes?

October 10, 2022

Rheumatology News

Breakthrough COVID studies lend support to use of new boosters in immunosuppressed patients

October 4, 2022

Rheumatology News

Sex differences seen in inflammatory arthritis health care use

September 30, 2022

Rheumatology News

Hormones’ impact described in transgender rheumatology patients

September 30, 2022

Rheumatology News

Around 10% of back pain patients referred by chiropractors have undiagnosed SpA

September 19, 2022

Rheumatology News

Spondyloarthritis disease activity measurement with ASDAS not influenced by gender

September 14, 2022

Rheumatology News

Filgotinib reduces flare risk in uveitis in phase 2 study

September 13, 2022

Rheumatology News

COX-2, TNF inhibitor combo appear to have limited role in reducing axSpA spinal damage progression

September 12, 2022

Rheumatology News

Bimekizumab effective for axSpA with or without prior TNFi treatment

September 9, 2022

Rheumatology News

AI algorithm detects erosions, ankylosis with high accuracy in patients with sacroiliitis

September 8, 2022

Rheumatology News

Should patients with PsA or ankylosing spondylitis with axial disease be ‘lumped’ or ‘split’?

September 8, 2022

Rheumatology News

OMERACT continues to set standards on research outcomes, enhancing the patient voice

August 30, 2022

Rheumatology News

Autoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depth

August 29, 2022